title: Tc-99m sestamibi scintimammography in the evaluation of response of breast carcinoma to chemotherapy.
authors.affiliation: Nuclear Medicine Division of Universidade Estadual de Campinas (UNICAMP), Brazil.
authors.forename: A I
authors.initials: AI
authors.lastname: Joaquim
authors.forename: A J
authors.initials: AJ
authors.lastname: Sagarra
authors.forename: C D
authors.initials: CD
authors.lastname: Ramos
authors.forename: R
authors.initials: R
authors.lastname: Coudry
authors.forename: R A
authors.initials: RA
authors.lastname: Sagarra
authors.forename: E E
authors.initials: EE
authors.lastname: Camargo
mesh_terms: D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D018270:Carcinoma, Ductal, Breast / Q000000981:diagnostic imaging / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005069:Evaluation Studies as Topic; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D015411:Mastectomy, Modified Radical; D009367:Neoplasm Staging; D017697:Premenopause; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi; D016896:Treatment Outcome
chemical_list: D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D019275:Radiopharmaceuticals; D015251:Epirubicin; D003520:Cyclophosphamide; D017256:Technetium Tc 99m Sestamibi; D005472:Fluorouracil